Medidata Solutions Inc. (MDSO)

74.10
0.95 1.30
NASDAQ : Technology Services
Prev Close 75.05
Open 75.09
Day Low/High 73.60 / 75.85
52 Wk Low/High 59.60 / 88.87
Volume 901.03K
Avg Volume 622.30K
Exchange NASDAQ
Shares Outstanding 59.68M
Market Cap 4.53B
EPS 0.80
P/E Ratio 86.20
Div & Yield N.A. (N.A)
Medidata To Present At Morgan Stanley Technology, Media & Telecom Conference

Medidata To Present At Morgan Stanley Technology, Media & Telecom Conference

Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday,...

Santen Pharmaceutical To Leverage Medidata Edge CTMS To Drive Future Growth In Ophthalmic Clinical Development

Santen Pharmaceutical To Leverage Medidata Edge CTMS To Drive Future Growth In Ophthalmic Clinical Development

Santen Pharmaceutical Co., Ltd, is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial operations, in...

Medidata And EClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement To Adopt Medical Imaging And Workflow Solutions

Medidata And EClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement To Adopt Medical Imaging And Workflow Solutions

Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC, an industry-leading provider of end-to-end data management services and cloud based products for clinical data optimization, is expanding their...

Medidata Named One Of 100 Most Sustainable Companies In The U.S. By Barron's Magazine

Medidata Named One Of 100 Most Sustainable Companies In The U.S. By Barron's Magazine

Medidata (NASDAQ:MDSO) has been named to Barron's first annual list of the " 100 Most Sustainable Companies" in the U.

Aperio Adds Medidata Edge ETMF And CTMS In Expansion Agreement

Aperio Adds Medidata Edge ETMF And CTMS In Expansion Agreement

Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the Medidata Clinical Cloud ® platform to include Edge eTMF and Edge CTMS, Medidata...

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research.

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research.

As clinical trials become more complex, sponsors and contract research organizations (CROs) are looking for a unified platform to help them overcome challenges such as dealing with disparate systems, complying with new...

(Graphic: Business Wire)

(Graphic: Business Wire)

Medidata (NASDAQ:MDSO) announced today that its virtual trials platform, Engage, is now being offered as a part of the Medidata Clinical Cloud®, providing researchers unmatched flexibility to conduct clinical trials...

Medidata Reports Record Full-Year And Fourth Quarter 2017 Results

Medidata Reports Record Full-Year And Fourth Quarter 2017 Results

Medidata (NASDAQ:MDSO) today announced its financial results for the fourth quarter and full year 2017 and provided detailed financial guidance for the full year 2018.

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research. (Graphic: Business Wire)

Medidata Clinical Cloud: One Platform For Data Managers, Clinical Operations, Investigators, And Patients To Accelerate The Science And Business Of Research. (Graphic: Business Wire)

Targeted therapies create new opportunities for patients, but can require complex trial design to achieve their promise.

Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Medidata And Syapse Announce Partnership To Bring Oncology Clinical Trials Into Precision Medicine Era

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to...

Medidata Schedules Fourth Quarter Earnings Conference Call For February 8, 2018

Medidata Schedules Fourth Quarter Earnings Conference Call For February 8, 2018

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its fourth quarter 2017 financial results before the open of the...

Qlik Announces New CEO

Qlik Announces New CEO

Qlik®, a leader in data analytics, today announced that its board appointed Mike Capone, former COO of Medidata Solutions (NASDAQ:MDSO), as Qlik's new CEO.

Medical Research Collaborating Center Selects Medidata To Meet Global Regulatory Requirements During Clinical Trials

Medical Research Collaborating Center Selects Medidata To Meet Global Regulatory Requirements During Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the Medical Research Collaborating Center (MRCC), one of the leading research...

Medidata To Present At J.P. Morgan 36th Annual Healthcare Conference

Medidata To Present At J.P. Morgan 36th Annual Healthcare Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann, chief financial officer, will present at the J.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ENTL, SCHL, WILC Downgrades: BLL, DLTH, INTL, MDSO, NTLA, PNR Initiations: PVAC Read on to get TheStreet Quant Ratings' detailed report:

New Quartesian Agreement With Medidata Expands Sponsor Access To The Medidata Clinical Cloud® During Clinical Trials

New Quartesian Agreement With Medidata Expands Sponsor Access To The Medidata Clinical Cloud® During Clinical Trials

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, announced that Quartesian, a leading data clinical research organization (CRO), has signed a new...

Medidata Solutions Stock Sees Short Interest Move 11% Higher

Medidata Solutions Stock Sees Short Interest Move 11% Higher

The most recent short interest data has been released for the 11/30/2017 settlement date, which shows a 609,963 share increase in total short interest for Medidata Solutions, Inc. , to 6,107,996, an increase of 11.09% since 11/15/2017.

Medidata SCA Wins Scrip Award For Best Technological Development In Clinical Trials - Sponsor Focused

Medidata SCA Wins Scrip Award For Best Technological Development In Clinical Trials - Sponsor Focused

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that the Medidata Synthetic Control Arm (SCA) was recognized at the 2017 Scrip...

Medidata Expands Partnership With CytomX Therapeutics To Centralize Management Of Regulated And Nonregulated Content

Medidata Expands Partnership With CytomX Therapeutics To Centralize Management Of Regulated And Nonregulated Content

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that CytomX Therapeutics, Inc.

Industry Survey Reveals Top 14 Technologies Necessary For A Unified EClinical Platform

Industry Survey Reveals Top 14 Technologies Necessary For A Unified EClinical Platform

Running a successful clinical trial or study is a complex and highly regulated process that requires vast operational expertise, a unified eClinical platform, and advanced statistical analytics.

Medidata Presenting At The 2017 Partnerships In Clinical Trials Europe Conference

Medidata Presenting At The 2017 Partnerships In Clinical Trials Europe Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced that Anthony Costello, vice president of mobile health, and Michael Hughes, lead product...

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the company's participation in the 29 th Annual Piper Jaffray Healthcare...

Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes Clinical Research With Multi-Year Medidata ETMF Agreement

Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes Clinical Research With Multi-Year Medidata ETMF Agreement

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that MEL MEDICAL Enterprises, has selected Medidata eTMF to carefully and...

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and ICON (NASDAQ: ICLR), a global provider of drug development solutions and services to the...

Medidata Honors 2017 Architects Of Hope Award Winners At Medidata NEXT Global

Medidata Honors 2017 Architects Of Hope Award Winners At Medidata NEXT Global

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the winners of the second annual Architects of Hope Awards.

Medidata Introduces New Strategic Monitoring Suite To Ensure Sponsors And Sites Meet ICH E6 Guidelines

Medidata Introduces New Strategic Monitoring Suite To Ensure Sponsors And Sites Meet ICH E6 Guidelines

Sites, Sponsors and CROs are facing increased costs and regulations in the area of monitoring.

Medidata To Host Financial Analyst Day On November 9 In New York City

Medidata To Host Financial Analyst Day On November 9 In New York City

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will host a Financial Analyst Day on Thursday, November 9, 2017 in New York...

Akros Pharma Inc. And Medidata Commemorate 10-year Partnership With Platform Expansion Agreement

Akros Pharma Inc. And Medidata Commemorate 10-year Partnership With Platform Expansion Agreement

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced today that Akros Pharma Inc.

Medidata Reports Record Third Quarter 2017 Results

Medidata Reports Record Third Quarter 2017 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced its financial results for the third quarter of 2017.

Horizon Pharma Plc To Leverage Medidata Clinical Cloud® And ETMF Solutions To Support Its Business Transformation

Horizon Pharma Plc To Leverage Medidata Clinical Cloud® And ETMF Solutions To Support Its Business Transformation

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that Horizon Pharma plc (NASDAQ: HZNP) has selected the Medidata Clinical Cloud®...

TheStreet Quant Rating: B (Buy)